$10.17
-1.08-9.60%
近くで: Jan 23, 4:00 PM EST
$10.21
0.040.39%
時間外: Jan 23, 6:37 PM EST
Comments
Loading...
インサイダー取引活動
最新の Personalis インサイダー取引活動を追跡します。Personalis 株の最近の購入、売却、市場への影響について最新情報を入手してください。
インサイダー活動とは何ですか?
インサイダー取引とは、役員、取締役、従業員などの企業内部関係者が自社の株式の取引を行う行為です。インサイダーの売買取引は、会社の将来の業績に対する彼らの信頼を知る貴重な洞察を提供します。
Personalis Inc のインサイダーは何をしているのですか?
Personalis Incでは、最近の内部関係者の活動が注目を集めています。過去 30 日間で、内部関係者は合計 - 株相当の - 株を売却したと報告しています。過去 30 日間に購入がなかったと報告します。
最近の注目すべきインサイダー売買
- 11 5, 2025、Christopher Hall、会社の PRESIDENT AND CEO sold 29.61K 株はそれぞれ $8.99 です。
Personalis Inc の所有権統計
発行済み株式数
84.693M
インサイダー所有株式数
1.450M
インサイダー保有率
1.63%
機関投資家保有株式
45.872M
機関投資家保有比率
51.7%
| Jan 23, 2026 | Aaron Tachibana | CFO AND COO | 0.00 | $10.33 | -$2.81K | SELL-OPTIONS | 0.00% | 164.46K | Jan 22 | View |
| Nov 28, 2025 | Aaron Tachibana | CFO AND COO | 0.00 | $9.97 | -$167.94K | SELL-OPTIONS | 0.00% | 164.46K | Nov 25 | View |
| Nov 05, 2025 | Christopher Hall | PRESIDENT AND CEO | -29.61K | $8.99 | -$266.21K | SELL | -16.63% | 148.49K | Nov 03 | View |
| Jul 30, 2025 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -452.00 | $6.57 | -$2.97K | SELL | -0.36% | 124.50K | Jul 28 | View |
| Jul 30, 2025 | Aaron Tachibana | CFO AND COO | -641.00 | $6.57 | -$4.21K | SELL | -0.39% | 164.46K | Jul 28 | View |
| May 20, 2025 | Aaron Tachibana | CFO AND COO | -1.29K | $4.95 | -$6.39K | SELL | -0.78% | 165.10K | May 16 | View |
| May 20, 2025 | Michael Stephen Moore | SVP AND CHIEF LEGAL OFFICER | -1.68K | $4.95 | -$8.29K | SELL | -2.54% | 64.20K | May 16 | View |
| May 20, 2025 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -910.00 | $4.95 | -$4.50K | SELL | -0.72% | 124.96K | May 16 | View |
| Jan 30, 2025 | Aaron Tachibana | CFO AND COO | -708.00 | $5.79 | -$4.10K | SELL | -0.42% | 166.39K | Jan 28 | View |
| Jan 30, 2025 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -519.00 | $5.79 | -$3.01K | SELL | -0.42% | 123.37K | Jan 28 | View |
| Dec 18, 2024 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -4.83K | $3.82 | -$18.47K | SELL | -3.76% | 123.89K | Dec 16 | View |
| Dec 18, 2024 | Michael Stephen Moore | SVP AND CHIEF LEGAL OFFICER | -1.51K | $3.82 | -$5.78K | SELL | -2.25% | 65.88K | Dec 16 | View |
| Dec 18, 2024 | Aaron Tachibana | CFO AND COO | -6.87K | $3.82 | -$26.22K | SELL | -3.95% | 167.10K | Dec 16 | View |
| Nov 20, 2024 | Aaron Tachibana | CFO AND COO | -1.31K | $3.79 | -$4.95K | SELL | -0.75% | 173.96K | Nov 18 | View |
| Nov 20, 2024 | Michael Stephen Moore | SVP AND CHIEF LEGAL OFFICER | -1.69K | $3.79 | -$6.42K | SELL | -2.45% | 67.39K | Nov 18 | View |
| Nov 20, 2024 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -921.00 | $3.79 | -$3.49K | SELL | -0.71% | 128.72K | Nov 18 | View |
| Nov 05, 2024 | Christopher Hall | PRESIDENT AND CEO | -26.44K | $5.38 | -$142.26K | SELL | -12.93% | 178.10K | Nov 01 | View |
| Aug 20, 2024 | Tempus AI Inc | 10% OWNER | 12.72M | $2.84 | $36.18M | BUY | ∞ | 12.72M | Aug 16 | View |
| Aug 01, 2024 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -524.00 | $2.97 | -$1.56K | SELL | -0.41% | 127.23K | Jul 30 | View |
| Aug 01, 2024 | Aaron Tachibana | CFO AND COO | -742.00 | $2.97 | -$2.20K | SELL | -0.42% | 175.27K | Jul 30 | View |
| Jun 20, 2024 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -5.05K | $1.29 | -$6.52K | SELL | -3.81% | 127.75K | Jun 17 | View |
| Jun 20, 2024 | Aaron Tachibana | CFO AND COO | -7.18K | $1.29 | -$9.26K | SELL | -3.92% | 176.01K | Jun 17 | View |
| Jun 20, 2024 | Michael Stephen Moore | SVP AND CHIEF LEGAL OFFICER | -1.58K | $1.29 | -$2.04K | SELL | -2.24% | 69.08K | Jun 17 | View |
| May 21, 2024 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -940.00 | $1.38 | -$1.30K | SELL | -0.70% | 132.81K | May 17 | View |
| May 21, 2024 | Aaron Tachibana | CFO AND COO | -1.33K | $1.38 | -$1.84K | SELL | -0.72% | 183.19K | May 17 | View |
| May 21, 2024 | Michael Stephen Moore | SVP AND CHIEF LEGAL OFFICER | -1.73K | $1.38 | -$2.39K | SELL | -2.39% | 70.67K | May 17 | View |
| May 02, 2024 | Michael Stephen Moore | SVP AND CHIEF LEGAL OFFICER | -4.52K | $1.37 | -$6.20K | SELL | -5.88% | 72.40K | Apr 30 | View |
| Mar 05, 2024 | WOODROW MYERS JR | — | 10.00K | $1.67 | $16.70K | BUY | 62.05% | 26.12K | Mar 01 | View |
| Jan 31, 2024 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -526.00 | $1.37 | -$720.62 | SELL | -0.41% | 128.87K | Jan 29 | View |
| Jan 31, 2024 | Aaron Tachibana | CFO AND COO | -716.00 | $1.37 | -$980.92 | SELL | -0.39% | 184.52K | Jan 29 | View |
| Dec 19, 2023 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -4.71K | $1.47 | -$6.92K | SELL | -3.51% | 129.40K | Dec 15 | View |
| Dec 19, 2023 | Aaron Tachibana | CFO AND COO | -6.75K | $1.47 | -$9.92K | SELL | -3.51% | 185.24K | Dec 15 | View |
| Dec 19, 2023 | Michael Stephen Moore | GENERAL COUNSEL | -1.48K | $1.47 | -$2.17K | SELL | -1.88% | 76.92K | Dec 15 | View |
| Nov 20, 2023 | Michael Stephen Moore | GENERAL COUNSEL | -1.72K | $1.04 | -$1.79K | SELL | -2.15% | 78.40K | Nov 16 | View |
| Nov 20, 2023 | Aaron Tachibana | CFO AND COO | -1.34K | $1.04 | -$1.40K | SELL | -0.70% | 191.98K | Nov 16 | View |
| Nov 20, 2023 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -940.00 | $1.04 | -$977.60 | SELL | -0.75% | 124.10K | Nov 16 | View |
| Nov 03, 2023 | Christopher Hall | PRESIDENT AND CEO | -20.46K | $0.93 | -$19.03K | SELL | -9.09% | 204.54K | Nov 01 | View |
| Aug 02, 2023 | Aaron Tachibana | CFO AND COO | -662.00 | $2.26 | -$1.50K | SELL | -0.34% | 193.33K | Jul 31 | View |
| Aug 02, 2023 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -485.00 | $2.26 | -$1.10K | SELL | -0.39% | 125.04K | Jul 31 | View |
| Jun 21, 2023 | Michael Stephen Moore | GENERAL COUNSEL | -1.51K | $2.07 | -$3.12K | SELL | -1.85% | 80.12K | Jun 16 | View |
| Jun 21, 2023 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -4.82K | $2.07 | -$9.97K | SELL | -3.70% | 125.53K | Jun 16 | View |
| Jun 21, 2023 | Aaron Tachibana | CFO AND COO | -6.90K | $2.07 | -$14.29K | SELL | -3.44% | 193.99K | Jun 16 | View |
| May 19, 2023 | Aaron Tachibana | CFO AND COO | -1.39K | $1.98 | -$2.75K | SELL | -0.69% | 200.89K | May 17 | View |
| May 19, 2023 | Michael Stephen Moore | GENERAL COUNSEL | -1.78K | $1.98 | -$3.53K | SELL | -2.14% | 81.63K | May 17 | View |
| May 19, 2023 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -971.00 | $1.98 | -$1.92K | SELL | -0.74% | 130.35K | May 17 | View |
| May 04, 2023 | Michael Stephen Moore | GENERAL COUNSEL | -5.10K | $2.29 | -$11.68K | SELL | -5.76% | 83.41K | May 02 | View |
| Mar 21, 2023 | Aaron Tachibana | CFO AND COO | -3.94K | $2.83 | -$11.16K | SELL | -1.91% | 202.28K | Mar 17 | View |
| Mar 21, 2023 | Richard Chen | CHIEF MEDICAL OFFICER AND EVP | -1.31K | $2.83 | -$3.72K | SELL | -0.99% | 131.32K | Mar 17 | View |
| Feb 02, 2023 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -767.00 | $2.20 | -$1.69K | SELL | -0.37% | 206.23K | Jan 31 | View |
| Feb 02, 2023 | Richard Chen | CHIEF MEDICAL OFFICER | -562.00 | $2.20 | -$1.24K | SELL | -0.42% | 132.63K | Jan 31 | View |
| Dec 22, 2022 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -3.84K | $1.92 | -$7.38K | SELL | -1.82% | 207.00K | Dec 20 | View |
| Dec 22, 2022 | Richard Chen | CHIEF MEDICAL OFFICER | -1.75K | $1.92 | -$3.36K | SELL | -1.30% | 133.19K | Dec 20 | View |
| Dec 19, 2022 | Michael Stephen Moore | GENERAL COUNSEL | -1.93K | $2.50 | -$4.83K | SELL | -2.13% | 88.51K | Dec 15 | View |
| Dec 19, 2022 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -7.18K | $2.50 | -$17.94K | SELL | -3.29% | 210.84K | Dec 15 | View |
| Dec 19, 2022 | Richard Chen | CHIEF MEDICAL OFFICER | -7.18K | $2.50 | -$17.94K | SELL | -5.05% | 134.94K | Dec 15 | View |
| Dec 06, 2022 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -4.36K | $2.60 | -$11.34K | SELL | -1.96% | 218.01K | Dec 02 | View |
| Dec 06, 2022 | Richard Chen | CHIEF MEDICAL OFFICER | -440.00 | $2.60 | -$1.14K | SELL | -0.31% | 142.12K | Dec 02 | View |
| Nov 18, 2022 | Richard Chen | CHIEF MEDICAL OFFICER | -1.29K | $2.71 | -$3.51K | SELL | -0.90% | 142.56K | Nov 16 | View |
| Nov 18, 2022 | Michael Stephen Moore | GENERAL COUNSEL | -2.04K | $2.71 | -$5.54K | SELL | -2.21% | 90.44K | Nov 16 | View |
| Nov 18, 2022 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -1.29K | $2.71 | -$3.51K | SELL | -0.58% | 222.38K | Nov 16 | View |
| Sep 22, 2022 | Richard Chen | CHIEF MEDICAL OFFICER | -1.58K | $3.48 | -$5.50K | SELL | -1.09% | 143.85K | Sep 20 | View |
| Sep 22, 2022 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -3.47K | $3.48 | -$12.09K | SELL | -1.53% | 223.67K | Sep 20 | View |
| Sep 08, 2022 | Richard Chen | CHIEF MEDICAL OFFICER | -420.00 | $3.33 | -$1.40K | SELL | -0.29% | 145.44K | Sep 02 | View |
| Sep 08, 2022 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -4.17K | $3.33 | -$13.88K | SELL | -1.80% | 227.14K | Sep 02 | View |
| Aug 01, 2022 | Richard Chen | CHIEF MEDICAL OFFICER | -632.00 | $3.91 | -$2.47K | SELL | -0.43% | 145.86K | Jul 28 | View |
| Aug 01, 2022 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -632.00 | $3.91 | -$2.47K | SELL | -0.27% | 231.31K | Jul 28 | View |
| Jun 21, 2022 | Richard Chen | CHIEF MEDICAL OFFICER | -1.56K | $3.29 | -$5.15K | SELL | -1.06% | 146.49K | Jun 17 | View |
| Jun 21, 2022 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -3.44K | $3.29 | -$11.32K | SELL | -1.46% | 231.94K | Jun 17 | View |
| Jun 17, 2022 | Michael Stephen Moore | GENERAL COUNSEL | -1.83K | $3.24 | -$5.94K | SELL | -2.42% | 73.89K | Jun 15 | View |
| Jun 17, 2022 | Richard Chen | CHIEF MEDICAL OFFICER | -6.82K | $3.24 | -$22.09K | SELL | -4.40% | 148.05K | Jun 15 | View |
| Jun 17, 2022 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -6.82K | $3.24 | -$22.09K | SELL | -2.82% | 235.38K | Jun 15 | View |
| Jun 06, 2022 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -4.19K | $3.59 | -$15.03K | SELL | -1.70% | 242.20K | Jun 02 | View |
| Jun 06, 2022 | Richard Chen | CHIEF MEDICAL OFFICER | -421.00 | $3.59 | -$1.51K | SELL | -0.27% | 154.87K | Jun 02 | View |
| May 18, 2022 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -1.29K | $4.86 | -$6.25K | SELL | -0.52% | 246.39K | May 16 | View |
| May 18, 2022 | Stephen John West | PRESIDENT AND CEO | -2.41K | $4.86 | -$11.70K | SELL | -0.63% | 382.44K | May 16 | View |
| May 18, 2022 | Michael Stephen Moore | GENERAL COUNSEL | -664.00 | $4.86 | -$3.23K | SELL | -0.87% | 75.72K | May 16 | View |
| May 18, 2022 | Richard Chen | CHIEF MEDICAL OFFICER | 272.00 | $4.81 | $1.17K | GRANT | 0.17% | 155.83K | Apr 29 - May 16 | View |
| May 04, 2022 | Michael Stephen Moore | GENERAL COUNSEL | -5.73K | $5.53 | -$31.70K | SELL | -6.98% | 76.38K | May 02 | View |
| Apr 15, 2022 | Stephen John West | PRESIDENT AND CEO | 0.00 | $1.84 | $118.55K | SELL-OPTIONS | 0.00% | 339.79K | Apr 13 | View |
| Mar 04, 2022 | Lightspeed Venture Partners Select IV LPRavi MhatreLightspeed General Partner Select IV LPLightspeed Ultimate General Partner Select IV LLCArif JanmohamedBarry EggersPeter Nieh | — | 314.75K | $9.86 | $3.10M | BUY | 19.09% | 1.96M | Mar 02 - Mar 03 | View |
| Mar 04, 2022 | Richard Chen | CHIEF MEDICAL OFFICER | -471.00 | $10.18 | -$4.79K | SELL | -0.30% | 157.33K | Mar 02 | View |
| Mar 04, 2022 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -4.51K | $10.18 | -$45.92K | SELL | -1.76% | 251.44K | Mar 02 | View |
| Feb 01, 2022 | Richard Chen | CHIEF MEDICAL OFFICER | -705.00 | $9.93 | -$7.00K | SELL | -0.44% | 157.81K | Jan 28 | View |
| Feb 01, 2022 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -705.00 | $9.93 | -$7.00K | SELL | -0.27% | 255.95K | Jan 28 | View |
| Jan 19, 2022 | Stephen John West | PRESIDENT AND CEO | -99.99K | $11.27 | -$1.13M | SELL | -25.94% | 285.46K | Jan 18 - Jan 19 | View |
| Dec 20, 2021 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -3.44K | $12.80 | -$43.99K | SELL | -1.32% | 256.66K | Dec 17 | View |
| Dec 20, 2021 | Richard Chen | CHIEF MEDICAL OFFICER | -1.56K | $12.80 | -$20.01K | SELL | -0.98% | 158.51K | Dec 17 | View |
| Dec 20, 2021 | Stephen John West | PRESIDENT AND CEO | -2.73K | $12.80 | -$34.97K | SELL | -0.70% | 385.44K | Dec 17 | View |
| Dec 17, 2021 | Stephen John West | PRESIDENT AND CEO | -97.27K | $13.42 | -$1.31M | SELL | -20.04% | 388.18K | Dec 16 | View |
| Dec 06, 2021 | Richard Chen | CHIEF MEDICAL OFFICER | -419.00 | $12.92 | -$5.41K | SELL | -0.52% | 80.07K | Dec 02 | View |
| Dec 06, 2021 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -4.18K | $12.92 | -$54.06K | SELL | -2.27% | 180.09K | Dec 02 | View |
| Dec 02, 2021 | Stephen John West | PRESIDENT AND CEO | -100.00K | $13.65 | -$1.36M | SELL | -17.08% | 485.44K | Nov 30 | View |
| Nov 19, 2021 | Stephen John West | PRESIDENT AND CEO | -2.35K | $17.04 | -$40.01K | SELL | -0.40% | 585.44K | Nov 17 | View |
| Nov 19, 2021 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -1.25K | $17.04 | -$21.35K | SELL | -0.68% | 184.28K | Nov 17 | View |
| Nov 19, 2021 | Richard Chen | CHIEF MEDICAL OFFICER | -542.00 | $16.86 | -$9.49K | SELL | -0.67% | 80.49K | Oct 29 - Nov 17 | View |
| Oct 14, 2021 | Stephen John West | PRESIDENT AND CEO | -100.00K | $19.33 | -$1.93M | SELL | -14.54% | 587.79K | Oct 12 | View |
| Sep 21, 2021 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -3.15K | $21.25 | -$66.98K | SELL | -1.67% | 185.53K | Sep 17 | View |
| Sep 21, 2021 | Richard Chen | CHIEF SCIENTIFIC OFFICER | -1.09K | $21.25 | -$23.12K | SELL | -1.32% | 81.03K | Sep 17 | View |
| Sep 07, 2021 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -3.82K | $21.92 | -$83.73K | SELL | -1.98% | 188.68K | Sep 02 | View |
| Sep 07, 2021 | Richard Chen | CHIEF SCIENTIFIC OFFICER | -291.00 | $21.92 | -$6.38K | SELL | -0.35% | 82.12K | Sep 02 | View |
| Aug 10, 2021 | Richard Chen | CHIEF SCIENTIFIC OFFICER | -4.44K | $21.19 | -$423.78K | SELL | -5.11% | 82.41K | Aug 06 | View |
| Jul 12, 2021 | Stephen John West | PRESIDENT AND CEO | 0.00 | $11.49 | -$2.43M | GRANT | 0.00% | 635.52K | Jul 08 | View |
| Jun 22, 2021 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -2.42K | $22.75 | -$55.08K | SELL | -1.31% | 182.50K | Jun 17 | View |
| Jun 22, 2021 | Richard Chen | CHIEF SCIENTIFIC OFFICER | -1.10K | $22.75 | -$25.05K | SELL | -1.45% | 74.98K | Jun 17 | View |
| Jun 10, 2021 | Stephen John West | PRESIDENT AND CEO | -220.00K | $11.43 | -$2.52M | SELL | -28.19% | 560.52K | Jun 08 | View |
| Jun 04, 2021 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -2.90K | $21.57 | -$62.53K | SELL | -1.54% | 184.92K | Jun 02 | View |
| Jun 04, 2021 | Richard Chen | CHIEF SCIENTIFIC OFFICER | -291.00 | $21.57 | -$6.28K | SELL | -0.38% | 76.08K | Jun 02 | View |
| Apr 05, 2021 | Richard Chen | CHIEF SCIENTIFIC OFFICER | -27.48K | $13.06 | -$1.02M | SELL | -32.99% | 55.83K | Apr 01 | View |
| Mar 19, 2021 | Richard Chen | CHIEF SCIENTIFIC OFFICER | -1.13K | $26.73 | -$30.20K | SELL | -1.34% | 83.32K | Mar 17 | View |
| Mar 19, 2021 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -2.45K | $26.73 | -$65.38K | SELL | -1.44% | 167.82K | Mar 17 | View |
| Mar 04, 2021 | Aaron Tachibana | CHIEF FINANCIAL OFFICER | -3.02K | $32.60 | -$98.52K | SELL | -1.74% | 170.27K | Mar 02 | View |
| Mar 04, 2021 | Richard Chen | CHIEF SCIENTIFIC OFFICER | -345.00 | $32.60 | -$11.25K | SELL | -0.41% | 84.45K | Mar 02 | View |
| Feb 03, 2021 | Richard Chen | CHIEF SCIENTIFIC OFFICER | -26.58K | $19.56 | -$1.54M | SELL | -23.86% | 84.79K | Feb 01 | View |
| Dec 21, 2020 | Richard Chen | — | -1.09K | $36.37 | -$39.53K | SELL | -0.97% | 111.37K | Dec 17 | View |
| Dec 21, 2020 | Aaron Tachibana | — | -2.39K | $36.37 | -$86.96K | SELL | -1.36% | 173.29K | Dec 17 | View |
| Dec 03, 2020 | Richard Chen | — | -293.00 | $14.22 | -$1.11M | OPTION EXERCISE | -0.26% | 112.46K | Dec 01 - Dec 02 | View |
| Dec 03, 2020 | Aaron Tachibana | — | -2.93K | $27.76 | -$81.23K | SELL | -1.64% | 175.68K | Dec 02 | View |
| Oct 21, 2020 | LLP Abingworth | — | -130.49K | $27.66 | -$3.61M | SELL | -3.36% | 3.75M | Oct 20 | View |
| Oct 20, 2020 | LLP Abingworth | — | -290.64K | $27.48 | -$7.99M | SELL | -6.96% | 3.88M | Oct 16 - Oct 19 | View |
| Oct 16, 2020 | LLP Abingworth | — | -85.63K | $27.05 | -$2.32M | SELL | -2.01% | 4.17M | Oct 14 - Oct 15 | View |
| Oct 14, 2020 | LLP Abingworth | 10% OWNER | -202.36K | $28.81 | -$5.83M | SELL | -4.53% | 4.26M | Oct 12 - Oct 13 | View |
| Oct 05, 2020 | Richard Chen | — | -2.55K | $11.25 | -$865.97K | OPTION EXERCISE | -2.21% | 112.75K | Oct 01 | View |
| Sep 21, 2020 | Richard Chen | — | -1.12K | $22.74 | -$25.47K | SELL | -0.96% | 115.30K | Sep 17 | View |
| Sep 21, 2020 | Aaron Tachibana | — | -2.46K | $22.74 | -$56.01K | SELL | -1.36% | 178.61K | Sep 17 | View |
| Sep 04, 2020 | Aaron Tachibana | — | -2.90K | $22.99 | -$66.65K | SELL | -1.58% | 181.07K | Sep 02 | View |
| Sep 04, 2020 | Richard Chen | — | -291.00 | $22.99 | -$6.69K | SELL | -0.25% | 116.42K | Sep 02 | View |
| Aug 20, 2020 | LLP Abingworth | — | -986.84K | $19.00 | -$18.75M | SELL | -18.11% | 4.46M | Aug 18 | View |
| Aug 18, 2020 | Richard Chen | — | -3.43K | $20.14 | -$644.39K | OPTION EXERCISE | -2.86% | 116.71K | Aug 14 | View |
| Aug 18, 2020 | KEN LUDLUM | — | -20.00K | $20.17 | -$403.39K | SELL | -16.67% | 100.00K | Aug 14 | View |
| Aug 18, 2020 | Lightspeed Venture Partners Select IV LPJeremy LiewRavi MhatreLightspeed General Partner Select IV LPLightspeed Ultimate General Partner Select IV LLCArif Janmohamed | — | 1.32M | $19.00 | $25.00M | BUY | 54.43% | 3.73M | Aug 14 | View |
| Jun 24, 2020 | Richard Chen | — | -1.08K | $12.37 | -$13.42K | SELL | -0.90% | 120.14K | Jun 22 | View |
| Jun 03, 2020 | Richard Chen | — | -289.00 | $13.19 | -$3.81K | SELL | -0.24% | 121.21K | Jun 01 | View |
| Jun 03, 2020 | Lightspeed Venture Partners Select IV LPJeremy LiewRavi MhatreLightspeed General Partner Select IV LPLightspeed Ultimate General Partner Select IV LLCArif Janmohamed | — | 458.45K | $13.81 | $6.33M | PURCHASE | 23.41% | 2.42M | Jun 01 - Jun 02 | View |
| Mar 11, 2020 | Richard Chen | — | 0.00 | $7.84 | -$7.84K | OPTION EXERCISE | 0.00% | 59.00K | Mar 09 | View |
| Mar 04, 2020 | Richard Chen | — | 0.00 | $8.76 | -$8.76K | OPTION EXERCISE | 0.00% | 59.00K | Mar 02 | View |
| Feb 27, 2020 | Richard Chen | — | 0.00 | $8.77 | -$885.77K | OPTION EXERCISE | 0.00% | 59.00K | Feb 25 | View |
| Jun 24, 2019 | PAUL RICCI | DIRECTOR | 40.00K | $17.00 | $680.00K | BUY | ∞ | 20.00K | Jun 24 | View |
| Jun 24, 2019 | KEN LUDLUM | DIRECTOR | 70.00K | $17.00 | $1.19M | BUY | 152.73% | 115.83K | Jun 24 | View |
よくある質問
Q
インサイダー取引は合法ですか？
A
インサイダー取引は、インサイダーがその取引をSECに報告する限り合法である。違法な証券取引は、インサイダーが受託者の義務に違反しているか、取引を報告していない場合に発生する。
Q
市場操作の例を教えてください。
A
インサイダー取引、パンプ・アンド・ダンプ・スキーム、フロント・ランニング、ウォッシュ・トレードはすべて市場操作の例である。インサイダーの資産の動きを追跡する投資家は、前進する前に、これらのインサイダーがなぜ株式を取引しているのかについて慎重に考えるべきである。
ブラウズ インサイダー取引 全銘柄の
PSNL インサイダー取引ニュース
こんな人も見ています
Benzinga
© 2026 Benzinga | All Rights Reserved